Microvascular endothelial dysfunction: a renewed appreciation of sepsis pathophysiology
Open Access
- 1 January 2001
- journal article
- Published by Springer Nature in Critical Care
- Vol. 5 (2), S1-5
- https://doi.org/10.1186/cc1332
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Clinical trial results with antithrombin III in sepsisCritical Care Medicine, 2000
- Prevention of Endotoxin-Induced Mortality by Antitissue Factor ImmunizationArchives of Surgery, 1996
- The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failureIntensive Care Medicine, 1996
- The Relationship between Plasminogen Activator Inhibitor-1 and Proinflammatory and Counterinflammatory Mediators in Children with Meningococcal Septic ShockThe Journal of Infectious Diseases, 1996
- Inhibition of endotoxin-induced activation of coagulation and fibrinolysis by pentoxifylline or by a monoclonal anti-tissue factor antibody in chimpanzees.Journal of Clinical Investigation, 1994
- Epidemic Meningococcemia and Purpura Fulminans with Induced Protein C DeficiencyClinical Infectious Diseases, 1993
- Efficacy of antithrombin III supplementation in animal models of fulminant Escherichia coli endotoxemia or bacteremiaAmerican Journal Of Medicine, 1989
- Protein C prevents the coagulopathic and lethal effects of Escherichia coli infusion in the baboon.Journal of Clinical Investigation, 1987
- Activation of Purified Human Plasma Prekallikrein Triggered by Cell Wall Fractions of Escherichia coli and Staphylococcus aureusThe Journal of Infectious Diseases, 1983
- Heparin in the Treatment of Experimental PeritonitisAnnals of Surgery, 1978